Norben Tea & Exports Full Year 2025 Earnings: ₹0.15 loss per share (vs ₹1.45 loss in FY 2024)
Norben Tea & Exports (NSE:NORBTEAEXP) Full Year 2025 Results
Key Financial Results
- Revenue: ₹76.5m (up 16% from FY 2024).
- Net loss: ₹1.77m (loss narrowed by 90% from FY 2024).
- ₹0.15 loss per share (improved from ₹1.45 loss in FY 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period

In the last 12 months, the only revenue segment was Cultivation, Manufacturing and Selling of Tea contributing ₹76.5m. The largest operating expense was General & Administrative costs, amounting to ₹41.9m (51% of total expenses). Explore how NORBTEAEXP's revenue and expenses shape its earnings.
Norben Tea & Exports shares are down 5.2% from a week ago.
Risk Analysis
Before you take the next step you should know about the 4 warning signs for Norben Tea & Exports that we have uncovered.
Valuation is complex, but we're here to simplify it.
Discover if Norben Tea & Exports might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:NORBTEAEXP
Norben Tea & Exports
Engages in the growing, manufacturing, and marketing of tea in India.
Moderate risk with imperfect balance sheet.
Market Insights
Weekly Picks

Is this the AI replacing marketing professionals?
Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business
The Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery
The Infrastructure AI Cannot Be Built Without
Recently Updated Narratives

Realty Income - A Fundamental and Historical Valuation
A Structured Counter‑Analysis of "The Leaking Dreadnought"

Alphabet Inc. (GOOG): The Gemini Era – Consolidating AI Dominance in 2026.
Popular Narratives

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share
Nu holdings will continue to disrupt the South American banking market

